[Progress in therapy for diabetes mellitus--insulin-resistance ameliorating agents].
Kaku
Kohei
K
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control; D050260:Carbohydrate Metabolism / Q000187:drug effects; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects; D008687:Metformin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D047495:PPAR gamma / Q000502:physiology; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology
D047495:PPAR gamma; D045162:Thiazolidinediones; D008687:Metformin; D000077205:Pioglitazone